Weight management
115 supplements analyzed and ranked by clinical evidence.
Supplement Evidence
Weight loss -7.3%
Waist/fat loss -2.8 cm
Fat loss +weight
Glucose/insulin β
Less waist/fat
+1.9kg weight gain
Lower insulin/TG
Body weight/waist β
Fat oxidation β
Weight loss +3.4 kg
Weight loss β14.4%
Blood pressure β
Waist/fat β
Visceral fat -53%
Weight loss +7.8kg
Weight loss: -5kg
Waist/fat loss: -2.6cm
Weight gain: +3β5 kg
Nicotine replacement: less gain
Weight loss/body fat β5.9kg
Steatorrhea β absorption
Satiety intake β
Body fat/lean mass
+10% intake drop
Fat loss/satiety + lipolysis
Weight gain/muscle preservation
Weight/fat loss
β4.6 kg
Improved satiety/metabolism
Lower fat mass
β8.7% fat mass
Slight muscle gain
Weight/BMI β
Waist/fat β
β5.2 kg
More weight loss
Fat/lean shifts
~+3.4 kg
Weight loss: +23.7% vs +19.6%
Fat/muscle shift
Metabolic support
Satiety/intake β
Weight loss/maintenance β
Body fat β
Weight loss, better waist/BMI
Fat-loss, better glucose
Growth +weight gain
Stunting/weight indices
Mortality β30%
Weight loss & fat β
Energy use +3-4%
Weight loss β7.3%
Less food intake
Lower body fat
Weight loss, fat -3.5kg
Glycemia/lipids, less weight
Fat loss, waist/BMI
Weight loss +5.6β6 kg
Fullness up, intake down
Weight loss + insulin
Less appetite + fat
Weight loss, fat sparing
-3.6 kg
Reduced intake, cravings
Weight loss +BMI
Fat loss +WC
Improved glucose/butyrate
Neutral weight: +0.4 kg
Lower intake: -97 kcal
Weight loss; BMIβ
Weight loss; β2.1%
Weight maintenance; waistβ
β weight/fat
β appetite/inflammation
Weightβ insulin/androgens
Child obesityβ +49%
Weight β, leptinβ
Weight β, BMIβ
Fat loss/EE +1.7kg
Fullness/intake -34%
Weight loss β3 to β6 kg
Waist/body fat β
BMI β1 to β2
Weight β, glucose/lipids
Weight β, appetiteβ
Lower diabetes risk
Weight loss +3.5kg
Improved weight maintenance
Weight -5kg, waist -10cm
Fat loss, weight loss
Weight/fat loss: β2.2 kg
Waist/VFA reduction
Weight loss: β5.4 kg
βBCAAs, βweight loss
βhunger, βintake
βsatiety hormones
Weight gain prevented
β2.5 kg
Fat oxidation up +4%
β fat mass/weight
β insulin resistance
βBMI/weight
βwaist circumference
Weight loss +7.3%
Fat loss β19.4%
Weight/BMI β ~6%
Waist β; blood sugar β
β appetite/intake
β waist/fat
β glucose/LDL
Fat β
Intake/gain β
Weight/fat loss β2.8 kg
Waist/BMI stabilized
Fat oxidation +25-29%
Body fat/weight loss
Insulin/lipid improvements
Weight loss + cholesterol
Weight gain +2.8 kg
Waist β3.8 cm
+fat oxidation
-energy intake
-weight/fat
Weight loss, lower BMI
Better glucose control
Weight β3.0 kg
BMI/body fatβ
Weight loss -5.5 kg
BMI/waist decrease
Weight -7.3%
+2.7 kg
Weight loss -14.8%
Body mass -4.2 kg
Sugar intake β42%
Body weight β3.4 kg
Weight loss, less appetite
~3.7 kg loss
More satiety, lower intake
BMI/body fat β
Fat loss markers β
Liver enzymes β
BMI/weight -3.9 kg
Weight loss +6.82 kg
Weight loss -0.8 to 1.5 kg
BMI/body fat β modestly
Lower intake, more satiety
Weight/fat β
BMI β
Weight β0.96 kg
Weight loss +5.85 kg
Weight maintenance +30%
Weight β5kg
Waist β12cm
Body fat -3.47%
BMI -3.31 kg/mΒ²
Strength gains +46 kg
Weight/fat loss β4.0kg
Reduced intake ~17%
Hunger/waist β
Weight/BMI β1.7 kg
Calories β229/day
Growth + lesions
+0.180 mg/kg
Growth efficiency +14%
Weight/BMI -2.5kg
GI absorption blockade
Weight neutral
Satiety β488 kJ
Weight loss β7.4 kg
Weight/body fat -8%
GLP-1/ DPP-4 +42
Weight β5.5 kg
Weight β1.4 kg
No extra loss
Weight/waist β
No exact %
Body fat down
Cholesterol improved
Weight: -4.7% / -2.3kg
Responders: 23 vs 1
Weight loss, waist β
Fat loss, BMI β
Slower emptying, β5.1 kg
β17% intake, less hunger
Body mass -5.0%
Waist -5.9%
Fat burning +23β28%
Lower intake -17%
Body fat/WHR down
Weight loss + insulinβ
Satiety/ bowel β
Intake β ~12%
Satiety/glucose β
Meal intake β 126 kcal
Bowel cleanliness unchanged
No intolerance reported
Insulin resistance improved
Adiponectin up, regularity +84%
Weight loss -1.7 kg
Insulin resistance improved
VS ratio β women
VAT β32.9 g
Mediterranean +1.6
Calories -195.5
Spices +1.9
Weight gain, FCR improved
WBC +8%
Glucose, LDL β
Cholesterol β
Triglycerides β31%
Glucose/cholesterol modestly lower
Appetite -hunger; satiety +
Insulin resistance -1.1, glucose -7
Weight -1.9 kg
Waist -3.5 cm
Pain relief, -weight
Glucose drop, less analgesics
Weight -5.5%
Triglycerides -29%
Weight loss -3 lb
No symptom change
Energy useβ, fatβ +18.6%
Weightβ, belly fatβ -4.1kg
Waist β2.4 cm
Weight/fat β
Lipid improvement, weight β1.2kg
Visceral fat β107g
Body fat β
EMUR unchanged
Fat/weight loss: β2.7kg
Body fat drop: β1.6kg
Lower glycaemia
Waist -4 cm
β glucose, NEFA
β hunger, ghrelin
BMI/waist down
LDL-C -0.86
BMI, lipids, BP down
slight edge over control
Fat mass β
Performance +
BMI, visceral fat β
Lipid ratios β
Better glucose, weight, ~0.9 mg V/day
Lower insulin resistance, gene expression
Visceral fat/waist β
Muscle mass β
Weight loss β5.3 kg
Body fat β4.5%
Satiety, hypoglycaemia
Weight loss +1.5kg
Weight gain +2.8 kg
No culture change
FFMβ, FMβ
PDEβ, DNA damageβ
Weight stable vs +4%
Omega-3 up
Fat burn +13β24%
Weight loss -10.6 kg
BMI β0.61
PBG/IR/CRP down
Fat loss, +16.8% free T
Lower body fat, more free T
BMI β
BMI +